MALAGUTTI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 1.184
AS - Asia 261
EU - Europa 247
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.695
Nazione #
US - Stati Uniti d'America 1.181
CN - Cina 126
SG - Singapore 87
UA - Ucraina 76
DE - Germania 44
GB - Regno Unito 43
TR - Turchia 41
FI - Finlandia 21
SE - Svezia 20
IT - Italia 18
BE - Belgio 9
FR - Francia 6
CA - Canada 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IN - India 2
LT - Lituania 2
RU - Federazione Russa 2
AL - Albania 1
AU - Australia 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
HK - Hong Kong 1
IE - Irlanda 1
IQ - Iraq 1
MX - Messico 1
NL - Olanda 1
PH - Filippine 1
Totale 1.695
Città #
Woodbridge 177
Fairfield 136
Ann Arbor 101
Chandler 93
Jacksonville 77
Houston 74
Singapore 72
Santa Clara 66
Ashburn 60
Wilmington 48
Seattle 44
Beijing 37
Cambridge 36
New York 32
Izmir 22
Princeton 21
Nanjing 20
Shanghai 13
Boardman 12
Bremen 10
Dearborn 10
San Diego 10
Brussels 9
Milan 8
Shenyang 8
Los Angeles 7
Nanchang 7
Auburn Hills 6
Jiaxing 6
Changsha 5
Helsinki 5
Jinan 5
Leawood 5
San Mateo 5
Ferrara 4
Philadelphia 4
Tappahannock 3
Tianjin 3
Addison 2
Falkenstein 2
Falls Church 2
Hebei 2
Hefei 2
Indiana 2
Jakarta 2
Mountain View 2
Norwalk 2
Toronto 2
Tucson 2
Verona 2
Washington 2
Zhengzhou 2
Augusta 1
Baghdad 1
Bogotá 1
Brno 1
Changchun 1
Copenhagen 1
Dublin 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Hong Kong 1
Hounslow 1
Hyderabad 1
Kunming 1
Lanzhou 1
London 1
Manila 1
Mexico City 1
Monmouth Junction 1
Munich 1
Nanning 1
Ningbo 1
North Bergen 1
Olomouc 1
Redwood City 1
Taizhou 1
Tirana 1
Totale 1.316
Nome #
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 155
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 153
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 151
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 145
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 118
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 118
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 116
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 110
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 92
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 88
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 78
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 77
Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. 75
Persistent Coronary No Flow After Wire Insertion Is an Early and Readily Available Mortality Risk Factor Despite Successful Mechanical Intervention in Acute Myocardial Infarction A Pooled Analysis From the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) Trials 72
CD34+ cells mobilization in myocardial infarction: a link with heart failure? 68
null 61
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 38
Totale 1.715
Categoria #
all - tutte 8.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020165 0 0 0 0 0 0 30 37 21 40 31 6
2020/2021185 18 19 7 21 8 13 7 24 2 25 29 12
2021/2022206 5 21 23 8 9 4 13 10 2 19 24 68
2022/2023193 23 4 8 30 37 28 5 23 22 1 8 4
2023/2024116 12 12 3 2 8 41 6 2 3 3 2 22
2024/2025188 8 6 37 12 65 59 1 0 0 0 0 0
Totale 1.715